ORGO
Organogenesis Holdings Inc.Company with tickers: ORGO
CIK
1661181
CUSIP
68621F102
Shares Outstanding
128,674,548
13F Activity (30d)
116 filings
113 filers
Price
$2.57
Market Cap
$343.56M
P/E Ratio
17.10
EPS (Diluted)
$0.15
52W High
$7.08
52W Low
$2.04
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $37,228,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $106,119,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $15,161,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-68,891,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-53,156,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.44 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.44 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |